ReviewUrologie (Heidelberg, Germany)2023

[Antibody-drug conjugates directed against NECTIN-4 as a new treatment option for patients with metastatic urothelial carcinoma].

Niklas Klümper et al.PubMed ↗Publisher ↗

No numbers read from the abstract.